Vif dimerization antagonists (OyaGen)

N/A

Report date: 2025/01/26 17:46:51

Base Information

Drug NameVif dimerization antagonists (OyaGen)

Drug Alias NameVDA (OyaGen)Vif dimerization antagonists (OyaGen)HIV-1 therapeutic (OyaGen)hA3G editing enzyme protector (OyaGen)CEM15 protector (OyaGen)

ClassificationSmall molecules > PeptidomimeticBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionVirion infectivity factor inhibitors

TargetsVirion infectivity factor

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesThomas Jefferson University

China Registration ClassN/A

Develop Information

Active CompaniesOyaGen Inc

Inactive CompaniesN/A

Active IndicationsHIV Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A